U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06986499) titled 'Standard Post Market Clinical Follow-up (PMCF) Study WSA 2025' on May 12.
Brief Summary: The purpose of the study is to follow-up on a released low-risk device as part of standard PMCF activities.
Study Start Date: Feb. 25
Study Type: INTERVENTIONAL
Condition:
Hearing Loss, Sensorineural
Intervention:
DEVICE: Hearing Aid Widex SmartRIC MRRLD 440
Receiver in Canal (RIC) hearing aid
DEVICE: Own hearing aid
subjects' own hearing aids, any brand, any model
Recruitment Status: COMPLETED
Sponsor: WSAUD A/S
Disclaimer: Curated by HT Syndication....